We're thrilled to announce the conclusion of the ReLink randomized controlled trial, with the enrollment of the final patient marking a monumental achievement in healthcare innovation. As we eagerly await the results, we anticipate sharing insights that could significantly shape the future of patient care. Stay tuned for upcoming updates!
